Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aldo451on Aug 14, 2020 12:38pm
312 Views
Post# 31409169

RE:Conference de Canaccord

RE:Conference de CanaccordI also thought it was a good presentation, at about minute 22, Kenneth answers question regarding BLA timeline. Basically, he states that they practically had to go back to ground-zero and invested $100m to make sure they get it right.
 
He goes on to talk about the positive financial impact approval will have and going after the USA market on their own with collaborations for other parts of the world.
 
Watch for yourself.
 
Cheers
Aldo 
<< Previous
Bullboard Posts
Next >>